Ion Beam Applications SA (EBR: IBAB)

Market Cap	323.91M
Revenue (ttm)	465.75M
Net Income (ttm)	7.85M
Shares Out	29.18M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	20.56
Dividend	0.17 (1.54%)
Ex-Dividend Date	Jun 19, 2024

Volume	38,253
Open	11.12
Previous Close	11.28
Day's Range	10.70 - 11.16
52-Week Range	8.26 - 14.56
Beta	1.00
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 21, 2024

About Ion Beam Applications

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclot...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,145
• Stock Exchange: Euronext Brussels
• Ticker Symbol: IBAB

Financial Performance

In 2023, Ascencio's revenue was 60.14 million, an increase of 8.94% compared to the previous year's 55.21 million. Earnings were 33.81 million, a decrease of -62.71%.